Large cell neuroendocrine carcinoma (LCNEC) is a rare but distinct entity of nasal cavity carcinomas. Only a very few cases have been reported in the nasal cavity. Its treatment is not well established. We report the case of a LCNEC in a 70 years old patient who presented with right nasal obstruction and epistaxis since 2 months. Diagnosis was confirmed by histological and immunohistochemical study. The patient underwent complete endoscopic removal of the tumor combined to adjuvant chemoradiotherapy. After 6 month follow-up, the patient was in complete clinical and radiological remission. We will discuss in this paper the various epidemiology, clinical features, pathological findings, differential diagnosis, and evolution of treatment of this uncommon malignancy in the light of current knowledge. Optimal treatment strategies are yet to be determined for this rare malignancy with poor prognosis including surgery and chemoradiotherapy.
Introduction
Neuroendocrine carcinoma is relatively uncommon in the sinonasal region. Very few cases of sinonasal large cell neuroendocrine carcinoma have been reported till date. In recent years, this variant has been recognized as a distinct entity. Otherwise, no agreement for adequate management has been reached. These aggressive tumors are requiring multimodality treatment that includes surgery as initial treatement and chemoradiotherapy. The focus of this paper is to report such extremely rare case and highlight recent developments in this pathology. of which occurred in the sinonasal tract [7] . In a review of 10 laryngeal LCNECs by Lewis et al. [8] , 9 patients (90%) presented with stage IV disease and 60% died of their disease. Kasafuka et al. 
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Conclusion
Large cell neuroendocrine carcinoma of the nasal cavity is an extremely rare and destructive neoplasm. Clinical presentations of this uncommon malignancy include non-specific symptoms.
Aggressive trimodality therapy seems to be the most effective approach to improve locoregional control and survival.
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